.Adjustments to Financial Statements
Difficulty: Advanced
Adjustments to Current Assets
Celgene Corp., adjusted current assets
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Current assets | |||||
| Adjustments | ||||||
| | Add: Allowance for doubtful accounts | |||||
| | Less: Current deferred tax assets1 | |||||
| After Adjustment | ||||||
| | Adjusted current assets | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Current deferred tax assets. See Details »
Adjustments to Total Assets
Celgene Corp., adjusted total assets
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total assets | |||||
| Adjustments | ||||||
| | Add: Operating leased assets1 | |||||
| | Add: Allowance for doubtful accounts | |||||
| | Less: Current deferred tax assets2 | |||||
| | Less: Non-current deferred tax assets (included in other non-current assets)3 | |||||
| After Adjustment | ||||||
| | Adjusted total assets | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Operating leased assets. See Details »
2 Current deferred tax assets. See Details »
3 Non-current deferred tax assets (included in other non-current assets). See Details »
Adjustments to Current Liabilities
Celgene Corp., adjusted current liabilities
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Current liabilities | |||||
| Adjustments | ||||||
| | Less: Current deferred tax liabilities1 | |||||
| | Less: Current portion of deferred revenue | |||||
| After Adjustment | ||||||
| | Adjusted current liabilities | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Current deferred tax liabilities. See Details »
Adjustments to Total Liabilities
Celgene Corp., adjusted total liabilities
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total liabilities | |||||
| Adjustments | ||||||
| | Add: Operating lease obligations1 | |||||
| | Less: Current deferred tax liabilities2 | |||||
| | Less: Non-current deferred tax liabilities3 | |||||
| | Less: Deferred revenue | |||||
| After Adjustment | ||||||
| | Adjusted total liabilities | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Operating lease obligations. See Details »
2 Current deferred tax liabilities. See Details »
3 Non-current deferred tax liabilities. See Details »
Adjustments to Stockholders' Equity
Celgene Corp., adjusted stockholders' equity
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Stockholders' equity | |||||
| Adjustments | ||||||
| | Less: Net deferred tax asset (liability)1 | |||||
| | Add: Allowance for doubtful accounts | |||||
| | Add: Deferred revenue | |||||
| After Adjustment | ||||||
| | Adjusted stockholders' equity | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Net deferred tax asset (liability). See Details »
Adjustments to Capitalization Table
Celgene Corp., adjusted capitalization table
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Short-term borrowings and current portion of long-term debt | |||||
| | Long-term debt, net of discount, excluding current portion | |||||
| | Total reported debt | |||||
| | Stockholders' equity | |||||
| | Total reported capital | |||||
| Adjustments to Debt | ||||||
| | Add: Operating lease obligations1 | |||||
| | Adjusted total debt | |||||
| Adjustments to Equity | ||||||
| | Less: Net deferred tax asset (liability)2 | |||||
| | Add: Allowance for doubtful accounts | |||||
| | Add: Deferred revenue | |||||
| | Adjusted stockholders' equity | |||||
| After Adjustment | ||||||
| | Adjusted total capital | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Operating lease obligations. See Details »
2 Net deferred tax asset (liability). See Details »
Adjustments to Revenues
Celgene Corp., adjusted net product sales
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Net product sales | |||||
| Adjustments | ||||||
| | Add: Increase (decrease) in deferred revenue | |||||
| After Adjustment | ||||||
| | Adjusted net product sales | |||||
Source: Based on data from Celgene Corp. Annual Reports
Adjustments to Reported Income
Celgene Corp., adjusted comprehensive income
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Net income | |||||
| Adjustments | ||||||
| | Add: Deferred income tax expense (benefit)1 | |||||
| | Add: Increase (decrease) in allowance for doubtful accounts | |||||
| | Add: Increase (decrease) in deferred revenue | |||||
| | Add: Other comprehensive income (loss) | |||||
| After Adjustment | ||||||
| | Adjusted comprehensive income | |||||
Source: Based on data from Celgene Corp. Annual Reports
1 Deferred income tax expense (benefit). See Details »
